Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores β1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors

Blood

Volumn 91, Issue 9, 1998, Pages 3414-3422

  Bhatia, Ravi ^a   Verfaillie, Catherine M ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CD34 ANTIGEN; COMPLEMENTARY DNA; HLA DR ANTIGEN; INTEGRIN; MESSENGER RNA;

ARTICLE; BONE MARROW CELL; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMOGENESIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032080097     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3414.3414_3414_3422     Document Type: Article

References (65)

1. Dowding CR, Gordon MY, Goldman JM: Primitive progenitor cells in the blood of patients with chronic granulocyte leukemia. Int J Cell Cloning 4:331, 1986
2. Williams DA, Rios M, Stephens C, Patel VP: Fibronectin and VLA-4 in hematopoietic stem cell-microenvironment interactions. Nature 352:438, 1991
3. Verfaillie CM, McCarthy JB, McGlave PB: Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their adhesion to fibronectin. J Exp Med 174:693, 1991
4. Miyake K, Weissman IL, Greenberger JS, Kincade PW: Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 173:599, 1991
5. Davis LS, Oppenheimer-Marks N, Bednarczyk JL, McIntyre BW, Lipsky PE: Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol 145:785, 1990
6. 1c. Science 269:1570, 1995
7. Adams JC, Watt FM: Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 340:307, 1989
8. Boudreau N, Sympson CJ, Werb Z, Bissell MJ: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891, 1995
9. Hurley RW, McCarthy JB, Verfaillie CM: Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96:511, 1995
10. Hurley RW, McCarthy JB, Wayner EA, Verfaillie CM: Monoclonal antibody crosslinking of the α4 or β1 integrin inhibits clonogenic hematopoietic progenitor proliferation. Exp Hematol 25:321, 1997
11. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF: Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myelogenous leukaemia. Nature 328:342, 1984
12. Upadhyaya G, Guba SC, Sih SA, Feinberg AP, Talpaz M, Kantarjian HM, Deisseroth AB, Emerson SG: Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest 88:2131, 1991
13. Verfaillie CM, McCarthy JB, McGlave PB: Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia: Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest 90:1232, 1992
14. Bhatia R, McCarthy JB, Verfaillie CM: Interferon-α restores normal negative regulation of CML progenitor proliferation by the marrow microenvironment by restoring normal β1 integrin mediated proliferation inhibition. Blood 87:3883, 1996
15. Rowley JD: A new consistent chromosome abnormality in chronic myelogenous leukemia. Nature 243:209, 1973
16. DeKlein A, Van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bostooma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 300:765, 1982
17. Daley GQ, Baltimore D: Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic leukemia-specific P210 bcr/abl protein. Proc Natl Acad Sci USA 85:9312, 1988
18. Daley GQ, Van Etten RA, Baltimore D: Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
19. Druker B, Okuda K, Matulonis U, Salgia R, Roberts T, Griffin JD: Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines. Blood 79:2215, 1992
20. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML: BCR-ABL induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adapter protein. Cell 75:175, 1993
21. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ: Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83:2038, 1994
22. Gishizky ML, Witte ON: Initiation of deregulated growth of multipotent progenitor cells by BCR-ABL in vitro. Science 256:836, 1992
23. McWhirter JR, Wang JYJ: An actin-binding function contributes to transformation by the BCR-ABL oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J 12:1533, 1993
24. Gotoh A, Miyazawa K, Ohyashiki K, Tauchi T, Boswell HS, Broxmeyer HE, Toyama K: Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) in human Ph-positive leukemia cell lines. Exp Hematol 23:1153, 1995
25. Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD, Druker BJ: Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem 269:22925, 1994
26. Salgia R, Li J-L, Lo SH, Brunkhorst B, Kansas GS, Sobhany ES, Sun Y, Pisick E, Hallek M, Ernst T, Tantravahi R, Chen LB, Griffin JD: Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210 BCR/ABL. J Biol Chem 270:5039, 1995
27. Szczylik C, Skorski T, Nicolaides NC, Manzella L, Malaguernara L, Venturelli D, Gewirtz AM, Calabretta B: Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science 253:562, 1991
28. Skorski T, Nieborowska-Skorska M, Nicolaides NC, Szczylik C, Iversen P, Iozzo RV, Zon G, Calabretta B: Suppression of Philadelphia 1 leukemia growth in mice by BCR-ABL antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 91:4504, 1994
29. + marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951, 1988
30. Verfaillie C, Blakholmer K, McGlave P: Purified primitive human hematopoietic progenitors with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 179:509, 1990
31. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR expression. Blood 79:1003, 1992
32. McCarthy JB, Hangen ST, Furcht LT: Human fibronectin contains distinct adhesion and motility-promoting domains for metastatic melanoma cells. J Cell Biol 102:179, 1986
33. Landsdorp PM, Dragowska W: Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruitment of quiescent precursors. Exp Hematol 21:1321, 1993
34. Bhatia R, McGlave PB, Dewald GW, Blazar BR, Verfaillie CM: Abnormal function of the bone marrow microenvironment in chronic myeiogenous leukemia: Role of malignant stromal macrophages. Blood 85:3636, 1995
35. Cashman J, Eaves AC, Eaves CJ: Regulated proliferation of primitive hematopoietic progenitors in long-term human marrow cultures. Blood 66:1002, 1985
36. Verfaillie C, McGlave PB: Leukemia inhibitory factor/human interleukin for DA cells: A growth factor that stimulates the in vitro development of multipotential human hemopoietic progenitors. Blood 77:263, 1991
37. Chomczynski P, Saachi N: Single step method of RNA isolation by acid guanadinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
38. Ely P, Miller WJ: Bcr/Abl mRNA detection following bone marrow transplantation for chronic myelogenous leukemia. Transplantation 52:1023, 1991
39. Vaerman JL, Lammineur C, Moureau P, Lewalle P, Deldime F, Blimenfeld M, Martiat, P: BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence specific but non-antisense mechanism. Blood 86:3891, 1995
40. Stein CA: Does antisense exist? Nature Med 1:1119, 1995
41. Juliano R: Signal transduction by integrins and its role in the regulation of tumor growth. Cancer Metastasis Rev 13:25, 1994
42. Ronnov Jensen L, Petersen OW, Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol Rev 76:69, 1996
43. Fearon ER: DCC: Is there a connection between tumorigenesis and cell guidance molecules? Biochem Biophys Acta 1288:M17, 1996
44. Kirkland MA, O'Brien SG, McDonald C, Davidson RJ, Cross NCP, Goldman JM: BCR-ABL antisense purging in chronic myeloid leukaemia. Lancet 342:614, 1993
45. Wagner RW: Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333, 1994
46. O'Brien SG, Kirkland MA, Melo JV, Hashmat Rao R, Davidson J, McDonald C, Goldman JM: Antisense BCR-ABL oligomers can cause non-specific inhibition of chronic myeloid leukemia cell lines. Leukemia 8:2156, 1994
47. Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E: Alternative splicing of RNAs transcribed from the human ABL gene and from the BCR-ABL fused gene. Cell 47:277, 1986
48. Bhatia R, Munthe H, Verfaillie CM: Decreased β1 integrin receptor capping in CML progenitors, reflecting abnormal receptor-cytoskeleton interactions, is normalized by interferon-α. Blood 88: 637a, 1996 (abstr, suppl 1)
49. Zhao RCH, Mclvor RS, Griffin JD, Verfaillie CM: Gene therapy for chronic myelogenous leukemia (CML): A retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo. Blood 90:4687, 1997
50. Hynes RO: Integrins: Versatility, modulation signaling in cell adhesion. Cell 69:11, 1992
51. Burridge K, Path K, Kelly T, Nuckolls G, Turner C: Focal adhesions: Transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu Rev Cell Biol 4:487, 1988
52. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268:233, 1995
53. Schwartz MA, Schaller MD, Ginsberg MH: Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 11:549, 1995
54. Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M, Chap H: Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton involves specific interactions of p85a with actin filaments and focal adhesion kmase. J Cell Biol 129:831, 1995
55. Salgia R, Brunkhorst B, Pisick E, Lo SH, Chen LB, Griffin JD: Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210 BCR/ABL. Oncogene 11:1149, 1995
56. Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Shau-Ching W, Zon G, Gewirtz A M, Perussia B, Calabretta B: Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood 86:726, 1995
57. de Jong R, ten Hoeve J, Heisterkamp N, Groffen J: Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia. J Biol Chem 270:21468, 1995
58. BCR/ABL to tne phosphoinositol-3' kinase pathway. Oncogene 12:839, 1996
59. McWhirter JR, Wang JYJ: Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol 11:1553, 1991
60. Renshaw MW, McWhirter JR, Wang JYJ: The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol Cell Biol 15:1286, 1995
61. + hematopoietic progenitors. Blood 88:1168, 1996
62. Bazzoni G, Carlesso N, Griffin JD, Hemler ME: Bcr/Abl expression stimulates integrin function in hematopoietic cell lines. J Clin Invest 98:521, 1996
63. Craig SW, Johnson RP: Assembly of focal adhesions: Progress, paradigms, and portents. Curr Opin Cell Biol 8:74, 1996
64. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, Clarkson B: p62dok: A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88:197, 1997
65. Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak M, Szczylik C, Zon G, Arlinghaus RB, Gewirtz A, Perussia B, Calabretta B: p120 GAP requirement in normal and malignant human hematopoiesis. J Exp Med 178:1923, 1993